WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome (Q24815527)

8

object named as

Andrew K Godwin

0 references

Gordon B. Mills

10

object named as

Gordon B Mills

0 references

author name string

María I Nunez

1

0 references

Daniel G Rosen

2

0 references

John H Ludes-Meyers

3

0 references

Hyunsuk Kil

5

0 references

Robert Page

6

0 references

Andres J P Klein-Szanto

7

0 references

Jinsong Liu

9

0 references

C Marcelo Aldaz

Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma

11

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

BMC Cancer

0 references

volume

5

0 references

issue

1

0 references

page(s)

64

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Loss of WWOX expression in gastric carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

An opposing view on WWOX protein function as a tumor suppressor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

WWOX, the common chromosomal fragile site, FRA16D, cancer gene

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

WWOX, the FRA16D gene, behaves as a suppressor of tumor growth

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Detection of progesterone receptor forms A and B by immunohistochemical analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1173095

Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer.

28 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Validation of tissue microarray technology in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Estrogen and progesterone receptors in ovarian epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

Allelic imbalance in selected chromosomal regions in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

The Characterization of the Common Fragile Site FRA16D and Its Involvement in Multiple Myeloma Translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-64

WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

Estrogen and progesterone receptors in ovarian neoplasms

1 reference

12 December 2020

Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen

1 reference

12 December 2020

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

12 December 2020

Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel

1 reference

12 December 2020

An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer

1 reference

12 December 2020

Steroid hormone receptors and long term survival in invasive ovarian cancer

1 reference

12 December 2020

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables

1 reference

12 December 2020